Celcuity Inc

Celcuity Inc is a pioneering biotechnology firm based in Minneapolis, Minnesota, dedicated to advancing cancer treatment. It specializes in creating molecularly targeted therapies by analyzing living tumor cells to pinpoint the abnormal cellular activities driving a patient's cancer. Its innovative CELsignia diagnostic platform guides the selection of targeted therapies. Celcuity is also developing Gedatolisib, aimed at treating certain types of advanced breast cancer, and is working on a test to measure signaling activity in breast and ovarian tumors, enhancing personalized treatment options.